88IV - Public company info - ImmuneOnco Biopharmaceuticals (Shanghai) Inc. -�H�Shares

Input the stock code or the company name

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. -�H�Shares, 01541.HK - Cash Flow	2022-12	2021-12
Net Cash Flow from Operating Activities	-238,710	-190,541
Net Cash Flow from Return on Investments & Servicing of Finance	7,793	686
Interest Received	8,580	1,577
Interest Paid	-787	-891
Dividend Received	0	0
Dividend Paid	0	0
Others	0	0
Taxes (Paid) / Refunded	0	0
Net Cash Flow from Investing Activities	-8,531	-110,299
Additions to Fixed Assets	-23,224	-108,835
Disposal of Fixed Assets	0	575
Increase in Investments	0	-329,000
Decrease in Investments	0	352,652
Net Cash Flow with Related Parties	0	0
Others	14,693	-25,691
Net Cash Flow before Financing Activities	-239,448	-300,154
Net Cash Flow from Financing Activities	180,167	793,924
New Loans	0	10
Loans Repayment	-5,803	-4,782
Fixed Income/Debt Instruments	0	0
Repayment of Fixed Income/Debt Instruments	0	0
Equity Financing	185,970	798,696
Net Cash Flow with Related Parties	0	0
Others	0	0
Increase(Decrease) in Cash & Cash Equivalents	-59,281	493,770
Cash & Cash Equivalents at Beginning of Year	668,326	183,674
Net Cash Flow due to Change in Exchange Rate/Others	26,167	-9,118
Cash & Cash Equivalents at End of Year	635,212	668,326
Currency	Renminbi	Renminbi
Unit
Auditor's Opinion	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - ImmuneOnco Biopharmaceuticals (Shanghai) Inc. -�H�Shares , 01541.HK